Dupilumab for management of capecitabine-induced hand-foot syndrome Journal Article

   

Authors:	Nykaza, I.; Sanford, R.; Gordon, A.
Article Title:	Dupilumab for management of capecitabine-induced hand-foot syndrome
Keywords:	cancer chemotherapy; clinical article; aged; unclassified drug; case report; drug dose reduction; drug withdrawal; capecitabine; follow up; loading drug dose; symptom; celecoxib; diclofenac; emollient agent; lidocaine; drug dose increase; drug substitution; hand foot syndrome; metastatic breast cancer; disease exacerbation; clobetasol; supportive care; urea; erosion; hand-foot syndrome; betamethasone dipropionate; human; female; article; oncodermatology; biologics; dupilumab; toxic erythema of chemotherapy; zinc sulfate; halobetasol
Journal Title:	JAAD Case Reports
Volume:	63
ISSN:	2352-5126
Publisher:	Elsevier Inc.
Date Published:	2025-09-01
Start Page:	105
End Page:	108
Language:	English
DOI:	10.1016/j.jdcr.2025.06.027
PROVIDER:	scopus
PMCID:	PMC12336648
PUBMED:	40791757
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-105011990957&doi=10.1016%2Fj.jdcr.2025.06.027&partnerID=40&md5=3d01f48982beeb1c7507e66e44d144e0
Notes:	Article -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/228091